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The purpose of this patient survey was to analyse the knowledge, experiences and attitudes 
regarding cardiac implantable electronic devices (CIED) in patients with pacemakers, 
implantable cardioverter defibrillators or cardiac resynchronization devices. Of 1644 patients 
with CIEDs from seven European countries, 88% were over 50 years of age. Most patients (90%) 
knew what device they were implanted with, and felt sufficiently informed about the indications 
for the therapy. As many as 42% of patients, needed additional information on the battery 
replacement and limitations in physical activity. The self-reported incidence of complications 
was 9%, and among these 9%, one quarter felt insufficiently informed about the possibility of 
complications and their management. The vast majority of patients (83%) were followed by face-
to-face visits, which was the most commonly preferred follow-up strategy by the patients.  Nearly 
75% of patients reported improved quality of life after device implantation, but still about 40% 
had worries about their device. Less than 20% had discussed with their physician or thought 
about the device handling in the end of life circumstance or end-stage disease. Notably, almost 
20% of the ICD patients did not wish to answer the question about what they wanted to be done 







Cardiac implantable electronic devices (CIED), including pacemakers, implantable cardioverter 
defibrillators (ICD) and cardiac resynchronization therapy (CRT) are the standard of care in 
various cardiac conditions and are used in a growing number of patients. CIEDs are effective in 
improving survival and quality of life. While indications, implantation rates and complications 
are well described among centres in Europe 
1
, patients’ experiences of being implanted and living 
with a CIED are less well explored. Being implanted with a device is a significant encounter for 
the individual, both physically and psychologically. Not only the diagnosis and implantation, but 
also the function of the device may affect and worry the patient. Furthermore, important 
questions of how to live with the device and what to do with the device in a situation of severe or 
end-stage disease may rise. Patients' beliefs and knowledge about their illness are important 
determinants of their coping responses to their illness and their treatment
2
.   
In the second patient survey performed by the European Heart Rhythm Association (EHRA)
3
, we 
explored the knowledge, perception of information and attitude towards the device among 
patients implanted with a CIED. 
Methods  
The prospective, multicentre, multinational snapshot survey included patients with CIEDs, 
implanted either recently or in the past. The survey was designed and approved by the EHRA 
Scientific Initiatives Committee (SIC). Patients with CIEDs were offered to participate in the 
survey by anonymously answering the questionnaire posted on an electronic platform and 
available via Internet or in the paper form.  The questionnaire contained 18 questions in the 
patients' native language. The survey was sent to the EHRA Electrophysiology (EP) Research 
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Network centres. The local ethic committee approval was obtained where needed, as per local 
policy. The EP Network centres were invited to participate on a voluntary basis. Patients were 
asked to submit their replies via the internet or in a paper form, either without any help or with 
technical guidance from medical staff or family members. The paper forms were subsequently 
uploaded online by the SIC staff. Data were collected anonymously. The study was conducted 
from November 2016 to February 2017.  
Results  
Patient population  
A total of 1644 patients (61% males) from 7 European countries participated in the survey. The 
number of patients from each country was as follows: 812 (49%) from Poland, 435 (26%) from 
Italy, 175 (11%) from France, 86 (5%) from Denmark, 55 (3%) from Norway, 32 (2%) from 
Romania, 16 (1%) from Spain and 33 (2%) were from other countries. There were 688 patients 
(42%) aged >75 years, 755 patients (46%) aged 50-75 years and 199 patients (12%) aged < 50 
years. Most patients were living with a partner (77%), while 20% were living alone and 3% lived 
in a nursing home. Regarding the patients’ education level, 37% of patients had a primary school 
education, 43% had graduated a secondary school and 21% of patients had a higher level of 
education. Almost half of patients filled the questionnaire by themselves (49%), 31% were helped 
by a health care professional and 20% used help from a friend or a family member.  
 
Device types and indications for implantations 
As self-reported, 41% of patients were implanted with antibradycardia pacemaker, 33% with an 
ICD, 8% with CRT and 7% of patients with CRT-D, whilst 10% of patients did not know the 
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type of device they were implanted with. The device was implanted 0-1 years, 1-3 years, 4-6 
years or 7-15 years ago each in approximately 25% of patients.  
Among the self-reported indications for device implantation, slow heart rhythm was the most 
common reason for device implantation (36%), followed by atrial fibrillation (23%), cardiac 
arrest or syncope (23%), prophylactic implantation due to high risk of cardiac arrest (20%) and 
heart failure (25%); 5% of patients did not know why they were implanted with their device.  
 
Device monitoring and follow-up 
Face-to-face regular hospital follow-up visits were the most common follow-up strategy (83% of 
patients), while 17% were followed remotely, with either not-so-frequent onsite visits (11%) or 
onsite visits scheduled as needed (4%). Most patients (51%) preferred to be followed by regular 
onsite visits, while 27% left the choice of follow-up strategy to their physician; 15% of 
participants wished to be monitored remotely, with less frequent face-to-face visits.  
 
Complications-related information  
Most patients (57%) reported that they were extensively informed about possible complications 
before the implantation, 29% reported that they had received some information, and 14% 
reported that they have been supplied with insufficient information. The self-reported incidence 
of complications was 9% (91% of patients reported no complication). Infections constituted half 
of the complications (4%).  If a complication had occurred, 72% of patients felt sufficiently 
informed about it, while the remaining 28% of patients felt insufficiently informed about the 
complication and its management. 
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Overall, most patients (44%) felt sufficiently informed, while the device battery capacity and 
possible limitations in physical activity (21% each) were the issues which patients would like to 
be more informed about (Figure 1). 
 
Quality of life with the device 
The vast majority of patients (69%) had never regretted to have received the device, while 24% 
of them had not given this question a second thought. A small proportion (7%) regretted or had 
sometimes regretted to have been implanted, usually because of complications and insufficient 
information about daily-life restrictions.  
In 68% of patients, the device had never caused any difficulties; however, 12% of patients 
reported difficulties regarding diagnostic procedures (e.g.., cardiac magnetic resonance), 7% 
regarding private life (e.g., travelling, relationship with partner), 4% of patients experienced 
professional problems (e.g., limitations to drive, etc.), 2% had insurance issues, and 0.4% of 
patients reported difficulties regarding pregnancy. 
Sixty-four percent of patients had no device-related worries; however, 36% of the patients were 
concerned about the delivery of shock, possible primary or daily activities-induced 
malfunctioning of the device, or had other worries (Figure 2).  
Only 6% of patients reported that the device affected their daily life. Restrictions in physical 
activity and the possibility of sleeping on the left side were the most commonly reported 
complaints. The quality of life after device implantation was clearly or slightly improved in the 
majority of patients, while it was impaired in only 5% of patients (Figure 3). 
 
Information and attitude in case of end-stage disease 
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Eighty-four percent of patients had not discussed what to do with their device in the end-of-life 
situation; 12% had briefly discussed the issue and 5% reported they have been thoroughly 
informed about possible alternatives by their physician. Of patients with an ICD, 66% had never 
thought about how would they wish their device to be handled in the case of an end-stage disease; 
6% of patients would prefer that their ICD remains active, 5% would consider to ask for the ICD 
inactivation, while 2% of patients reported that they had thought about the question but they did 
not have a clear preference. Notably, 18% of participants preferred not to answer this question.  
Discussion 
This prospective, international, multicentre patient survey conducted in 7 European countries 
provided important insights into the contemporary patients’ knowledge, information and attitudes 
regarding living with a CIED.  The survey revealed the unmet need for more information with 
respect to battery replacement and physical activity. Nevertheless, the survey showed that 
European patients implanted with a CIED were well informed of the device indication and the 
type of device they were implanted with. In most patients, the quality of life increased or 
remained unchanged after device implantation, and only a very few patients regretted the device 
implantation. Only a minority of patients had discussed with their physician what to do with the 
device in the case of end-stage disease or end-of-life situation, and there was a tendency among 
patients to avoid this question.  
 
Patients’ knowledge, need of information and quality of life after device implantation 
The patients participating in this survey were generally well informed about their type of device 
and the indication for the implantation, with less than 10% of them not able to answer these 
questions. Of note, almost half of the patients were >75 years of age, indicating a good 
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knowledge also in the elderly. However, the need of information about the device was still not 
met, because only 40% of patients felt they had no unresolved questions and 40% had worries 
regarding their device.  
Patient information is of uppermost importance, as it will reduce stress of living with a CIED and 
the disappointments in case of complications. Information on the device should be ideally given 
orally, during face-to-face conversations, and in written form, with the possibility to discuss 
further questions with an appropriate health care provider. This survey showed that patients felt 
well informed about complications concerning the implantation procedure. However, among 
those who reported to have had complications, as many as a quarter of subjects felt insufficiently 
informed about potential complications and their management.  Furthermore, even questions 
concerning the way of life with the device during the follow up were less well answered. The 
need for further information was most often related to device functioning (e.g., battery 
replacement, etc.) and to physical activity.  Physical activity is an important question to address 
when living with a CIED, and, of course, it has to be individualized in accordance with the type 
of device and the underlying diseases.  Current international recommendations only suggest 
moderate leisure-time physical activity to patients with an ICD 4, 5. Recent studies have indicated 
that the device per se should not restrict physical activity. In patients used to an active life-style, 
restrictions in activity are particularly limiting. A multinational registry showed that many 
athletes with ICDs engage in competitive sports, without physical injury, or failure to terminate 
the arrhythmia
6
. Physicians should carefully consider the patients need for activity, when 
choosing leads, devices programming, preventive bradycardic medication, physical rehabilitation 
and psychological counselling, in order to allow the maximum benefit and the minimum harm for 





Interestingly, 73% of patients reported to have improved their quality of life after device 
implantation. Considering that 56% of our population received a pacemaker (pacemaker: 41%; 
CRT devices: 15%), also a substantial proportion of ICD patients had an increase in their quality 
of life. This may be explained by improved medical treatment, regular follow-up visits and 
psychological effects. However, patients worried about their devices and 40% reported concerns 
about technical problems. In particular, 10% of patients were frightened to receive a shock from 
the ICD. Although focus has been paid to reduce appropriate and inappropriate shocks, this 
problem still seems to be considerable.  
Only a very small minority of patients regretted the device implantation. The reasons given by 
these patients were most frequently associated with device complications and with restrictions of 
physical activity.  
 
Monitoring of the device  
Most patients followed regular onsite- visits and only a minority was followed remotely. Remote 
follow-up of devices allows for fewer in-office visits in combination with earlier detection of 
relevant findings
8, 9
. However, most patients wished to continue regular onsite-visits, and only 
15% wanted more extensive remote monitoring with less onsite visits. This result may reflect a 
lack of awareness about potential benefits of remote monitoring. The cost-benefit ratio of remote 





Information and attitude in case of patients’ end-stage disease 
Although nearly half of patients were > 75 years of age, only a minority of them had discussed 
with their physician or, even, thought about what to do when end of life is approaching. 
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Physicians and patients may be reluctant to discuss these problems, particularly when the clinical 
situation seems to be far away. Most physicians have experienced the dilemma of turning off a 
pacemaker or an ICD in terminal patients. For many years, the ethical debate about pacemakers 
has focused on whether and under what circumstances they may be turned off in end of life 
care
10
.  Interestingly, and of note, almost 20% of the ICD patients in this survey did not want to 
answer the question about what they wanted to do with their device in such a situation. This may 
reflect an unwillingness to approach the argument. The current guidelines on prevention of 
sudden cardiac death give only a IIa class recommendation to the discussions of end-of-life issues 
with patients, both before ICD implantation and at significant points along the illness trajectory
11
. 
Furthermore, recommendations class IIa state that ICD deactivation should be considered when 
clinical conditions deteriorate
11
. This issue remains difficult and requires attention and awareness 
among physicians and health care personnel. Incorporation of patients' values and preferences in 




Patients were generally well informed about their device and indications. However, there was 
further need for information, mainly regarding device functioning, battery replacement and 
physical activity. Quality of life improved in the majority of patients, also including ICD patients. 
Questions about what to do with the device at the patient’s end of life were rarely discussed by 








Bar graph showing the need of information or support among 1644 patients with implantable 
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Bar graph showing quality of life after device implantation among 1644 patients with implantable 
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